Should we continue to target the platelet-activating factor pathway in septic patients?

Crit Care Med. 2004 Feb;32(2):585-8. doi: 10.1097/01.CCM.0000110730.38696.9C.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • 1-Alkyl-2-acetylglycerophosphocholine Esterase / therapeutic use*
  • APACHE
  • Humans
  • Sepsis / drug therapy*
  • Sepsis / mortality
  • Survival Rate

Substances

  • 1-Alkyl-2-acetylglycerophosphocholine Esterase